John Bernard Payne, Director at Nexvet Biopharma, holds 9.79K shares in Nexvet Biopharma (Ticker: NVET), holds ― shares in Zivo Bioscience (Ticker: ZIVO).

See the Hottest Stocks Based on Insider Trading >

John Bernard Payne
Nexvet Biopharma (NVET)
Director

Ranked #44,875 out of 78,624 Corporate Insiders

Profitable Transactions

2 out of 4 Profitable Transactions

Average Return

-4.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

John Bernard Payne does not currently own shares as a corporate insider.

A breakdown of John Bernard Payne's holdings

See the Top Stocks by Insiders

Insider Roles

Zivo Bioscience
(ZIVO)

Director

Roles that John Bernard Payne holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Nexvet Biopharma
(NVET)

Rating:Informative Buy

Date:Jul 01, 2016 - Jul 01, 2017

Return:+39.70%

The most profitable trade made by John Bernard Payne

See the Latest Stocks Traded by Insiders

John Bernard Payne's Trading History

NVET

Nexvet Biopharma

Aug 02, 2017

―

Uninformative Sell

114.21K

$65.82K

ZIVO

Zivo Bioscience

―

Director

―

List of latest transactions for each holding click on a transaction to see John Bernard Payne's performance on stock

See All Insider Trading from Today

John Bernard Payne insider profile FAQ

What is the percentage of profitable transactions made by John Bernard Payne?

The percentage of profitable transactions made by John Bernard Payne is 50%.

What is the average return per transaction made by John Bernard Payne?

The average return per transaction made by John Bernard Payne is -4.50%.

What stocks does John Bernard Payne hold?

John Bernard Payne holds: NVET, ZIVO stocks.

What was John Bernard Payne’s latest transaction?

John Bernard Payne latest transaction was an Uninformative Sell of $114.21K.

What was John Bernard Payne's most profitable transaction?

John Bernard Payne’s most profitable transaction was an Informative Buy of NVET stock on July 1, 2016. The return on the trade was 39.70%.

What is John Bernard Payne's role in Nexvet Biopharma?

John Bernard Payne's role in Nexvet Biopharma is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

John Bernard Payne Insider Profile

John Bernard Payne Nexvet Biopharma (NVET)Director